article Open AccessTop 1% cited
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
European Heart Journal · 2013 · Vol. 34(39) · pp. 3035–3087
Authors Task Force Members(ESCP Business School)Lars Rydén✉Peter J. Grant✉Stefan D. AnkerChristian BerneFrancesco CosentinoNicolas DanchinChristi DeatonJavier EscanedHans‐Peter HammesHeikki HuikuriMichel MarreNikolaus MarxLinda MellbinJan ÖstergrenCarlo PatronoPetar SeferovicMiguel Sousa‐UvaMarja‐Riitta TaskinenMichał TenderaJaakko TuomilehtoPaul ValensiJosé Luis ZamoranoESC Committee for Practice GuidelinesJosé Luis ZamoranoStephan AchenbachHelmut BaumgartnerJeroen J. BaxHéctor BuenoVerónica DeanChristi DeatonÇetin ErolRobert FagardRoberto FerrariDavid HasdaiArno W. HoesPaulus KirchhofJuhani KnuutiPhilippe KolhPatrizio LancellottiAleš LinhartPetros NihoyannopoulosMassimo PiepoliPiotr PonikowskiPer Anton SirnesJuan TamargoMichał TenderaAdam TorbickiWilliam WijnsStephan WindeckerDocument ReviewersGuy De Backer(ESCP Business School)Per Anton Sirnes(ESCP Business School)Eduardo Alegría Ezquerra(ESCP Business School)Angelo Avogaro(ESCP Business School)Lina Badimón(ESCP Business School)Е. И. Баранова(ESCP Business School)Helmut Baumgartner(ESCP Business School)John Betteridge(ESCP Business School)Antonio Ceriello(ESCP Business School)Robert Fagard(ESCP Business School)Christian Funck‐Brentano(ESCP Business School)Dietrich C. Gulba(ESCP Business School)David Hasdai(ESCP Business School)Arno W. Hoes(ESCP Business School)John Kjekshus(ESCP Business School)Juhani Knuuti(ESCP Business School)Philippe Kolh(ESCP Business School)Eli Lev(ESCP Business School)Christian Mueller(ESCP Business School)Ludwig Neyses(ESCP Business School)Peter M. Nilsson(ESCP Business School)Joep Perk(ESCP Business School)Piotr Ponikowski(ESCP Business School)Željko Reiner(ESCP Business School)Naveed Sattar(ESCP Business School)Volker Schächinger(ESCP Business School)André Scheen(ESCP Business School)Henrik Schirmer(ESCP Business School)Anna Strömberg(ESCP Business School)Svetlana Sudzhaeva(ESCP Business School)Juan Tamargo(ESCP Business School)Margus Viigimaa(ESCP Business School)Charalambos Vlachopoulos(ESCP Business School)Robert G. Xuereb(ESCP Business School)
Abstract
with the European Association for the Study of Diabetes (EASD).
Diabetes Treatment and ManagementLipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsMedicineDiabetes mellitusInternal medicineIntensive care medicineEndocrinology
MeSH terms
Smoking PreventionAdolescentAdultAgedCardiovascular DiseasesChildChild, PreschoolDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic AngiopathiesDietFemaleGlycated HemoglobinHumansInfant
Citations
1,949
FWCI
136.14
field-weighted impact
References
562
Percentile
100%
vs. same field & year
Citations per year
Cited by
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
European Heart Journal · 2017 · 3,217 citations
Diabetic dyslipidemia
Metabolism · 2014 · 515 citations
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
European Heart Journal · 2019 · 4,808 citations
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
European Heart Journal · 2021 · 5,933 citations
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management
European Heart Journal · 2014 · 1,651 citations
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
European Heart Journal · 2016 · 11,387 citations
References
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
Journal of the American College of Cardiology · 2010 · 4,016 citations
Effects of Intensive Glucose Lowering in Type 2 Diabetes
New England Journal of Medicine · 2008 · 7,836 citations
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
New England Journal of Medicine · 2000 · 8,641 citations
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
The Lancet · 1996 · 6,493 citations
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
New England Journal of Medicine · 2008 · 7,365 citations
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
New England Journal of Medicine · 2001 · 6,459 citations
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
Diabetes Care · 2007 · 1,524 citations
Long-term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors in Individuals With Type 2 Diabetes Mellitus
Archives of Internal Medicine · 2010 · 1,164 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
